Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

FMC Buys Epax For Omega-3 Oils

by Melody M. Bomgardner
July 29, 2013 | A version of this story appeared in Volume 91, Issue 30

Specialty chemical firm FMC has acquired Epax, the omega-3 fatty acid business of Norway’s Trygg Pharma, in a transaction worth $345 million. The acquisition will expand FMC’s presence in the nutraceutical market. As part of the deal, FMC will supply high-concentration omega-3 oil to Trygg for use as an active pharmaceutical ingredient. Currently, FMC sells ingredients such as microcrystalline cellulose, carrageenan, and pectin to food and beverage customers. According to FMC, omega-3 fatty acids are a $2.1 billion-per-year industry growing by 12–15% annually. Other chemical firms have snapped up omega-3 businesses in recent years. DSM purchased Ocean Nutrition Canada in 2012 and Martek in 2011, and BASF bought Pronova early this year. Most omega-3 fatty acids are derived from fish oil, although Martek obtains its products via fermentation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.